BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | 11.83% | 49.61% | -50.59% | -2.12% | 44.91% |
| Total Depreciation and Amortization | 5.88% | -26.10% | -20.69% | -6.45% | -6.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.48% | -74.70% | 258.37% | 7.08% | 52.87% |
| Change in Net Operating Assets | -189.56% | 70.25% | 178.72% | -1,466.67% | -120.79% |
| Cash from Operations | -236.42% | 59.86% | 40.55% | -30.00% | 49.17% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 100.00% | 33.57% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 550.91% | 44.64% | 0.00% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -145.33% | 271.81% | 42.89% | -14.66% | 32.09% |
